Suliman Khan | Medicine | Research Excellence Award

Published on by Research Hypothesis

Research Excellence Award

Suliman Khan
Affiliation Zhengzhou University
Country China
Scopus ID 57192387486
Documents 136
Citations 7,308
h-index 40
Subject Area Medicine
Event International Research Hypothesis Excellence Award
ORCID 0000-0003-4954-0748
Suliman Khan
Zhengzhou University | China

Suliman Khan is associated with Zhengzhou University and has contributed to scholarly activities within the field of medicine through research dissemination, academic collaboration, and publication output. Scholarly indicators including publication count, citation performance, and author metrics suggest a sustained contribution to scientific literature and research visibility. Recognition through the International Research Hypothesis Excellence Award reflects alignment with measurable academic impact indicators and institutional research standards.[1]

Abstract

This article presents a structured academic overview of Suliman Khan, emphasizing institutional affiliation, publication metrics, research output indicators, and award suitability considerations. Quantitative scholarly indicators including document production and citation metrics provide evidence of research engagement and broader academic influence within medicine.[2]

Keywords

The Research Excellence Award in Medical Research recognizes outstanding scholarly contributions that advance scientific discovery and healthcare innovation. Strong Academic Metrics, enhanced Research Visibility, and meaningful Citation Analysis reflect the impact and influence of research activities, demonstrating excellence in knowledge dissemination, collaboration, and contributions to the global scientific community.

Introduction

Academic recognition frequently combines quantitative assessment and qualitative scholarly influence. Citation metrics, institutional affiliations, publication records, and sustained research engagement collectively support evaluation frameworks used in contemporary academic environments.[3]

Research Profile

The available research profile demonstrates sustained academic participation through publication activity and citation performance. Indicators such as an h-index of 40 and more than seven thousand citations suggest broad scholarly dissemination and measurable engagement with published work.[1]

Research Contributions

Demonstrated active engagement in advancing and disseminating scholarly medical research through international academic collaborations, contributions to scientific literature, and impactful research activities. Sustained efforts have supported scientific visibility and recognition, reflected through growing citation metrics and broader research impact.

Publications

Publication records indexed through scholarly databases indicate extensive scientific dissemination. Representative DOI records may include indexed biomedical publications and collaborative outputs within medicine-related research areas.[4]

Research Impact

Research influence is often interpreted through citation frequency, interdisciplinary use, and sustained scholarly relevance. Citation accumulation and publication consistency contribute to academic visibility and institutional recognition.[2]

Award Suitability

The International Research Hypothesis Excellence Award evaluates research significance, measurable scholarly activity, and contribution patterns. Publication volume, citation performance, and institutional research engagement align with typical criteria used in academic recognition frameworks.[5]

Conclusion

The documented academic profile reflects sustained research participation supported by publication output and scholarly metrics. Such indicators contribute to broader evaluation systems used for international academic awards and institutional recognition activities.

References

  1. Elsevier. (n.d.). Scopus author details: Suliman Khan, Author ID 57192387486. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57192387486
  2. ORCID Foundation. ORCID profile and scholarly researcher identification records.
    https://orcid.org/0000-0003-4954-0748
  3. Hirsch, J.E. An index to quantify an individual’s scientific research output.
    https://doi.org/10.1073/pnas.0507655102
  4. Biomedical DOI Reference Record.
    https://doi.org/10.1016/j.cell.2020.11.004
  5. International Research Hypothesis Excellence Award Program Information.
    https://researchhypothesis.com/

Tony Bader | Medical | Research Excellence Award

Published on by Research Hypothesis

Dr. Tony Bader | Medical | Research Excellence Award

American University of Beirut | Lebanon

Dr. Tony Bader is a multidisciplinary researcher and dental surgeon specializing in artificial intelligence, digital transformation, and governance, with a strong focus on healthcare systems and institutional decision-making. His work explores the integration of AI-driven tools in diagnostics, clinical practice, and public institutions, emphasizing accountability, efficiency, and ethical frameworks. He contributes to academic research, policy discussions, and interdisciplinary collaborations addressing the societal impact of emerging technologies. With professional experience spanning clinical practice, research, consulting, and leadership, he advances innovative approaches to digital adoption, organizational strategy, and evidence-based decision-making, bridging healthcare, technology, and governance for sustainable and impactful outcomes.

View Orcid Profile

Featured Publications

Xue Li | Medicine and Health Sciences | Research Excellence Award

Published on by Research Hypothesis

Mrs. Xue Li | Medicine and Health Sciences | Research Excellence Award

Mrs. Xue Li | Medicine and Health Sciences | Associate Professor | Shanghai University | China

Mrs. Xue Li is an Associate Professor in the School of Psychology at Shanghai University of Sport and a recognized scholar in the interdisciplinary domains of sports psychology and women’s mental health. She holds a doctoral degree in psychology from a nationally accredited university, where her academic training emphasized experimental psychology, cognitive assessment, and applied mental health research. Professionally, Mrs. Xue Li has developed a strong academic profile through her teaching, research leadership, and curriculum innovation within higher education, particularly in psychology programs integrating sport science and behavioral health. Her research interests focus on cognitive and emotional regulation in female populations, attention bias, psychological risk assessment, time perception in athletes, and the mental health benefits of structured physical and mind–body interventions such as yoga. Mrs. Xue Li possesses advanced research skills in experimental design, psychological measurement, virtual simulation development, data analysis, and interdisciplinary collaboration, enabling her to translate theoretical models into applied educational and clinical contexts.

View ORCID Profile

Featured Publications

Regular Yoga Modulates Attention Bias During the Luteal Phase in Women with Premenstrual Syndrome

– Brain Sciences, Multidisciplinary Digital Publishing Institute

Claudia Lommatzsch | Medicine and Health Sciences | Visionary Research Award 2971

Published on by Research Hypothesis

Dr. Claudia Lommatzsch | Medicine and Health Sciences | Visionary Research Award

Dr. Claudia Lommatzsch | Medicine and Health Sciences | Senior Physician | St. Franziskus-Hospital | Germany

Dr. Claudia Lommatzsch is a distinguished clinician-scientist in ophthalmology, recognized for her significant contributions to glaucoma diagnostics, ocular imaging, and translational vision research. She received her medical education from a leading German medical university and later achieved advanced academic qualification through habilitation, reflecting her expertise in independent research and university-level teaching. Professionally, Dr. Claudia Lommatzsch has built a strong career as a senior physician and researcher within a major ophthalmology department, where she seamlessly integrates clinical responsibilities with innovative research activities. Her professional experience spans patient-centered glaucoma care, advanced imaging diagnostics, and interdisciplinary research collaborations that connect clinical ophthalmology with laboratory-based biomarker analysis. Her primary research interests include glaucoma pathophysiology, optical coherence tomography, OCT angiography, vascular and molecular biomarkers, pediatric ocular imaging, and disease progression assessment, with a particular emphasis on improving early diagnosis and personalized treatment strategies. In the middle of her academic career trajectory, she has authored 28 documents, accumulated 316 citations, and achieved an h-index of 8, demonstrating measurable scientific impact and consistent research productivity within indexed international journals.

Citation Metrics (Scopus)

500

400

300

200

100

0

Citations316

i10index28

h-index8

🟦 Citations    🟥 Documents      🟩 h-index

View scopus Profile
         View ORCID Profile

Featured Publications

ET-1, MMPs, ZAG, and APN Link Reduced Ocular Perfusion to Glaucoma

– Biomolecules, Open Access

Assessment of Chronic Degenerative Eye Disease Progression

– Editorial, Open Access

Laurie Margolies | Medicine and Health Sciences | Excellence in Research Award

Published on by Research Hypothesis

Dr. Laurie Margolies | Medicine and Health Sciences | Excellence in Research Award

Dr. Laurie Margolies | Medicine and Health Sciences | MD at Icahn School of Medicine at Mount Sinai | United States

Dr. Laurie Margolies is a distinguished academic physician and internationally recognized expert in breast imaging and diagnostic radiology, known for her leadership in integrating advanced imaging technologies and artificial intelligence into clinical cancer care. She received her undergraduate education at Brown University with an academic focus on biomedical ethics, followed by her medical degree from Yale University School of Medicine, where she developed a strong foundation in clinical medicine and research ethics. Dr. Laurie Margolies completed rigorous postgraduate training in internal medicine, diagnostic radiology, and advanced cross-sectional imaging, equipping her with comprehensive expertise across mammography, ultrasound, MRI, and tomosynthesis. Professionally, Dr. Laurie Margolies has held progressive academic appointments culminating in a full professorship in diagnostic, molecular, and interventional radiology at a leading academic medical center, while simultaneously serving in senior health-system leadership roles including Vice Chair and System Chief for Breast Imaging.

Citation Metrics (Scopus)

2500

2000

1500

1000

500

0

Citations2177

i10index92

h-index19

🟦 Citations    🟥 Documents    🟩 h-index


View Scopus Profile

Featured Publications

Performance of an Artificial Intelligence Support System on Screening Mammography Cases Proceeding to Stereotactic Biopsy
– Cancers (Open Access)
The Tyrer-Cuzick Risk Model: Is It Effective for All Races?
– Clinical Imaging
Patient Perception of Artificial Intelligence in Breast Imaging: A Pilot Survey Study
– Clinical Imaging
Suspicion for Sarcoma: Clinical Presentation, Multi-Modality Imaging Evaluation, and Ultrasound Artificial Intelligence-Based Decision Support
– Cancers (Open Access)
Breast Lymphoma: Imaging Features, Clinical Presentation, and Ultrasound Artificial Intelligence Decision Support
– Clinical Imaging
Artificial Intelligence for Assessment of Digital Mammography Positioning Reveals Persistent Challenges
– Journal of Breast Imaging
Breast Arterial Calcifications on Mammography: A Review of the Literature
– Review Article
Identifying Frequently Endorsed Benefits and Barriers to Breast Cancer Screening for African-Born Women in the NYC Metropolitan Area: A Pilot Study
– Journal of Racial and Ethnic Health Disparities
Low-Dose Chest CT: Participating in the Rise of Breast Density Awareness
– Journal of Women’s Health

Gabriela Gurau | Medicine and Health Sciences | Excellence in Research Award

Published on by Research Hypothesis

Prof. Dr. Gabriela Gurau | Medicine and Health Sciences | Excellence in Research Award 

Prof. Dr. Gabriela Gurau | Medicine and Health Sciences | Excellence in Research Award | Physician | The Lower Danube University | Romania

Prof. Dr. Gabriela Gurău is an accomplished Romanian medical researcher, clinician, and academic leader with extensive contributions to the fields of clinical laboratory medicine, infectious diseases, and metabolic disorders. She holds a Ph.D. in Medical Sciences from the University of Medicine and Pharmacy “Carol Davila,” Bucharest, complemented by advanced certifications in diabetes, nutrition, metabolic diseases, and laboratory medicine from the Ministry of Health and the Training Center for Doctors and Pharmacists. Currently serving as Professor Habil. at the Faculty of Medicine and Pharmacy, University “Dunarea de Jos” of Galați, she also fulfills the role of Head of the Clinical Laboratory at the Clinical Emergency Hospital for Children “Sfântul Ioan.” Throughout her professional journey, Prof. Dr. Gabriela Gurău has demonstrated exceptional skill in integrating clinical diagnostics with translational research, focusing on pediatric infections, antibiotic resistance, microbiological profiling, and metabolic disorders. Her research interests include pathogen surveillance, microbial resistance mechanisms, pediatric metabolic health, and the interplay between microbiota and systemic diseases. With an active research portfolio, she has participated in numerous national and international projects, including innovative studies funded by PN II, AUF, and institutional grants, contributing significantly to Romania’s biomedical research landscape. She is the author and co-author of impactful peer-reviewed articles published in leading scientific journals indexed in Scopus and Web of Science, such as Life, Viruses, International Journal of Molecular Sciences, Applied Sciences, and Infection and Drug Resistance, reflecting her commitment to scientific excellence and knowledge dissemination. Her strong research skills span molecular diagnostics, laboratory analytics, data interpretation, and interdisciplinary collaboration, all of which reinforce her as a versatile scientist bridging clinical medicine and public health research. Recognized for her scholarly achievements and leadership, Prof. Dr. Gabriela Gurău has been a key figure in organizing medical conferences like MedFarmLab, served as Head of the Department of Morphological and Functional Sciences, and contributed actively to professional societies and research committees. Her dedication has earned her respect as a mentor, educator, and innovator in Romanian academia. Prof. Dr. Gabriela Gurău’s career exemplifies a synthesis of scientific rigor, community service, and academic distinction, underpinned by her mission to improve pediatric healthcare outcomes through evidence-based research. With her established reputation, international collaborations, and evolving leadership roles, Prof. Dr. Gabriela Gurău continues to advance the frontiers of laboratory medicine and inspire emerging generations of biomedical scientists worldwide.

Profile: Scopus | ORCID | Google Scholar

Featured Publications 

  1. Matache, E. R., Gurău, G., Stoian, V. I., Zaharia, A. E., Ciocoiu, M., Maftei, N. M., & Tutunaru, D. (2025). Bordetella pertussis in children: A retrospective analysis of the clinical impact and the role of vaccination. Life, 15(10), 1514.

  2. Matache, E. R., Gurău, G., Raileanu, C. R., Zaharescu, A., Popa, G. V., Maftei, N. M., & Tutunaru, D. (2025). Pathogen profile of children hospitalised with viral respiratory infections in Galati County, Romania. Viruses, 17(4), 586.

  3. Ursu, M., Cretu-Stuparu, M., Gurău, G., Nitoi, L. C., Nechita, A., & Arbune, M. (2024). An epidemiological perspective on new pediatric cases of type 1 diabetes and vitamin D deficiency in South-East Romania: A retrospective study. Children, 11(10), 1162.

  4. Radaschin, D. S., Iancu, A. V., Ionescu, A. M., Gurău, G., Niculet, E., Bujoreanu, F. C., & Tatu, A. L. (2024). An eastern county from a European eastern country—The characteristics of cutaneous microbiome in psoriasis patients—Preliminary results. Life, 14(6), 678.

  5. Radaschin, D. S., Iancu, A. V., Ionescu, A. M., Gurău, G., Niculet, E., Bujoreanu, F. C., & Popa, L. G. (2024). Comparative analysis of the cutaneous microbiome in psoriasis patients and healthy individuals—Insights into microbial dysbiosis: Final results. International Journal of Molecular Sciences, 25(19), 10583.

  6. Iancu, A. V., Arbune, M., Zaharia, E. A., Tutunaru, D., Maftei, N. M., Peptine, L. D., Tocu, G., & Gurău, G. (2023). Prevalence and antibiotic resistance of Enterococcus spp.: A retrospective study in hospitals of Southeast Romania. Applied Sciences, 13(6), 3866.

  7. Arbune, M., Gurău, G., Niculet, E., Iancu, A. V., Lupasteanu, G., Fotea, S., Vasile, M. C., & Tatu, A. L. (2021). Prevalence of antibiotic resistance of ESKAPE pathogens over five years in an infectious diseases hospital from South-East Romania. Infection and Drug Resistance, 14, 2369–2378.

 

Muhammad Bilal Afridi | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Dr. Muhammad Bilal Afridi | Medicine and Health Sciences | Best Researcher Award

Dr. Muhammad Bilal Afridi | Medicine and Health Sciences | Best Researcher Award | Pharmaceutical | Abdul Wali Khan University Mardan | Pakistan

Dr. Muhammad Bilal Afridi is a dedicated pharmaceutical scientist and clinical pharmacist recognized for his expertise in drug synthesis, pharmacological modeling, and computational chemistry. With a profound academic background and more than a decade of professional experience, Dr. Afridi has established himself as a leading researcher in the domain of synthetic and therapeutic drug development. He earned his Ph.D. in Pharmaceutical Sciences from Abdul Wali Khan University, Mardan, where his doctoral research focused on the synthesis, characterization, computational studies, and pharmacological potential of synthetic curcumin derivatives aimed at addressing diabetes and amnesia-related disorders. His earlier academic milestones include an M.Phil in Pharmaceutical Sciences from Abdul Wali Khan University and a Doctor of Pharmacy (Pharm-D) from Kohat University of Science and Technology. Professionally, Dr. Muhammad Bilal Afridi has served as a pharmacist at the Institute of Kidney Diseases (IKD), Peshawar, where he managed hospital pharmacy operations, clinical pharmacy services, and patient safety programs. His leadership extended to training junior pharmacists, supervising pharmacy interns, and participating in institutional Drug and Therapeutic Committees. His previous tenures at Rehman Medical Institute and D. Watson Chemist allowed him to develop robust skills in patient counseling, prescription review, pharmacovigilance, and rational drug use. Dr. Afridi’s research interests encompass computational drug design, molecular docking, pharmacodynamics, and synthesis of bioactive compounds, reflecting his interdisciplinary approach that bridges chemistry, pharmacology, and computational biology. His published works in highly regarded journals, including Computational Biology and Chemistry, Inorganic Chemistry Communications, and Current Molecular Pharmacology, contribute significantly to advancing medicinal chemistry and pharmaceutical innovation. He has demonstrated strong analytical and technical skills in density functional theory (DFT) modeling, ADMET prediction, and spectral analysis. Dr. Muhammad Bilal Afridi’s professional competencies include teaching, mentoring, research supervision, and scientific writing, backed by proficiency in tools like EndNote and MS Office. His contributions have been acknowledged through multiple peer-reviewed publications, collaborations with international researchers from Türkiye and Saudi Arabia, and recognition in academic circles for his commitment to scientific excellence. He continues to serve as a role model for young researchers in Pakistan through his dedication to patient-centered research and academic mentorship. His unwavering commitment to bridging pharmaceutical sciences and clinical applications makes him a strong candidate for recognition in global research excellence. Dr. Muhammad Bilal Afridi stands as an emerging leader with a promising future in international pharmaceutical research, committed to innovation, integrity, and impactful contributions to human health and medicine.

Profile: Scopus

Featured Publications 

  1. Afridi, M. B., Sardar, H., Serdaroğlu, G., Shah, S. W. A., Alsharif, K. F., & Khan, H. (2024). SwissADME studies and density functional theory (DFT) approaches of methyl substituted curcumin derivatives. Computational Biology and Chemistry, 112, 108153. (Cited by 8)

  2. Afridi, M. B., Sardar, H., Serdaroğlu, G., Shah, S. W. A., Alsharif, K. F., & Khan, H. (2024). In silico ADMET and DFT analysis of methoxy substituted curcumin derivatives. Inorganic Chemistry Communications, 168, 112943. (Cited by 6)

  3. Afridi, M. B., Khan, H., Ali Shah, S. W., Zafar, M., Almalki, A. S., Ghias, M., & Rahman, N. (2022). In-vivo anti-nociceptive activities of Schiff bases aldehyde derivatives of 4-aminoantipyrine and their molecular docking studies. Main Group Chemistry, 21(2), 373–386. (Cited by 10)

  4. Afridi, M. B., Khan, H., Akkol, E. K., & Aschner, M. (2021). Pain perception and management: Where do we stand? Current Molecular Pharmacology, 14(5), 678–688. (Cited by 25)

  5. Afridi, M. B., Sardar, H., Shah, S. W. A., Serdaroğlu, G., & Khan, H. (2025). Exploring anticholinergic and anti-amnesic potential of methyl substituted monocarbonyl curcumin derivatives. European Journal of Pharmacology, 950, 182653. (Cited by 2)

  6. Afridi, M. B., Khan, H., & Shah, S. W. A. (2023). Computational evaluation of synthetic curcumin analogs for neuroprotective potential using molecular docking approaches. Journal of Molecular Structure, 1287, 135623. (Cited by 4)

  7. Afridi, M. B., Sardar, H., & Khan, H. (2023). Pharmacological insights into curcumin derivatives: A computational and experimental perspective. Bioorganic Chemistry, 137, 106707. (Cited by 3)

 

Yun-Bae Kim | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Prof. Yun-Bae Kim | Medicine and Health Sciences | Best Researcher Award

Prof. Yun-Bae Kim | Medicine and Health Sciences | Best Researcher Award | Professor | Chungbuk National University | South Korea

Prof. Yun-Bae Kim, a distinguished professor at the Department of Toxicology, College of Veterinary Medicine, Chungbuk National University, Republic of Korea, is an eminent scholar in the fields of toxicology, neurobiology, and regenerative medicine. Holding both a Doctor of Veterinary Medicine (D.V.M.) and a Ph.D. in Veterinary Medicine from Seoul National University, Prof. Yun-Bae Kim has built an outstanding academic and research career dedicated to the study of neurotoxicopathology, neurodegenerative diseases, and stem cell-based therapeutic innovations. His research primarily explores the toxicopathologic mechanisms of chemicals, brain aging, and the development of gene-modified stem cells to treat degenerative diseases such as Alzheimer’s disease, Parkinson’s disease, and cerebral palsy. With over 370 peer-reviewed publications and patents indexed in Scopus, PubMed, and other global databases, Prof. Yun-Bae Kim scholarly impact spans across both scientific research and industrial innovation. His professional experience includes serving as a Senior Researcher at the Agency for Defense Development, where he contributed to biomedical and toxicologic defense research, and later as a Visiting Professor at the University of British Columbia Hospital in Canada, where he developed neural stem cells effective against Alzheimer’s dementia. Prof. Yun-Bae Kim research excellence is supported by his leadership roles as CEO of Designed Cells Co., Ltd. in Korea, Vice-Chair of Qingdao Sinder Designed Stem Cells Co., Ltd. in China, Co-Chair of Designed Cells Europe D.O.O. in Croatia, and Chief Scientific Officer of ThanEver Inc. He has also served as Editor-in-Chief of Laboratory Animal Research for a decade and continues to contribute as an editorial board member or associate editor for several prestigious journals such as Molecules, Journal of Ginseng Research, and Journal of Chemical Neuroanatomy. His research interests encompass toxicologic pathology, neuropharmacology, stem cell biotechnology, and regenerative therapies targeting chronic and neurodegenerative conditions. His scientific skills include molecular toxicology, bioinformatics, experimental pathology, and stem cell engineering. Recognized in global directories such as Marquis Who’s Who and 21st Century Korean Roll (Who’s Who), Prof. Yun-Bae Kim has received numerous honors and has contributed extensively to scientific societies and academic collaborations worldwide. His dedication to advancing interdisciplinary biomedical sciences, coupled with his visionary leadership in academia and biotechnology, firmly establishes him as a transformative figure whose continued work promises to enhance global standards in neurotoxicology, regenerative medicine, and therapeutic innovation.

Profile:  Google scholar | Scopus

Featured Publications

  1. Kim, Y.-B., et al. (2024). BVN008, Diphtheria-tetanus-acellular pertussis combined vaccine has no effects on fertility and prenatal and postnatal developmental toxicity in female Sprague-Dawley rats. Reproductive Toxicology, 126, 108587. (1 citation)

  2. Kim, Y.-B., et al. (2024). The Role of Prolactin in Amniotic Membrane Regeneration: Therapeutic Potential for Premature Rupture of Membranes. Endocrinology.

  3. Kim, Y.-B., et al. (2023). Repeated Intravenous Administration of Human Neural Stem Cells Producing Choline Acetyltransferase Exerts Anti-Aging Effects in Male F344 Rats. Cells, 12(5). (2 citations)

  4. Kim, Y.-B., et al. (2023). An Exosome-Rich Conditioned Medium from Human Amniotic Membrane Stem Cells Facilitates Wound Healing via Increased Reepithelization, Collagen Synthesis, and Angiogenesis. Cells, 12(4). (12 citations)

  5. Kim, Y.-B., et al. (2023). Preventive Effects of Exosome-Rich Conditioned Medium From Amniotic Membrane-Derived Mesenchymal Stem Cells for Diabetic Retinopathy in Rats. Translational Vision Science & Technology, 12(6). (10 citations)

  6. Kim, Y.-B., et al. (2023). Effectiveness of Combinational Treatments for Alzheimer’s Disease with Human Neural Stem Cells and Microglial Cells Over-Expressing Functional Genes. International Journal of Molecular Sciences, 24(9). (6 citations)

  7. Kim, Y.-B., et al. (2023). Antioxidative and Anti-Inflammatory Activities of Rosebud Extracts of Newly Crossbred Roses. Nutrients, 15(10). (3 citations).

 

Katarzyna Madziarska | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Assoc. Prof. Dr. Katarzyna Madziarska | Medicine and Health Sciences | Best Researcher Award

Medicine and Health Sciences | Head of Department | Wroclaw Medical University | Poland

Assoc. Prof. Dr. Katarzyna Madziarska is a distinguished Polish clinician-scientist, educator, and researcher whose career has been dedicated to advancing the fields of diabetology, nephrology, and internal medicine through outstanding academic leadership, clinical practice, and research excellence. She obtained her MD and PhD from Wroclaw Medical University, where she currently serves as Head of the Clinical Department of Diabetology, Hypertension, and Internal Diseases, a position that allows her to combine patient care with cutting-edge research and medical education. Her professional experience spans decades, including roles as resident, assistant, senior assistant, adjunct, and ultimately associate professor, giving her a comprehensive understanding of clinical and academic medicine. She has been actively involved in postgraduate medical training and serves as a coordinator for trainees, a member of doctoral and habilitation committees, and a lecturer at both undergraduate and postgraduate levels. Her research interests are focused on micro- and macrovascular complications of diabetes, diabetic nephropathy, chronic kidney disease, transplantology, and the long-term health consequences of COVID-19. She has authored 112 documents, 1,076 citations, and 15 h-index, demonstrating her sustained scientific output and influence within the international medical community. Her research skills include designing and coordinating clinical trials (Phase III and IV) as a principal investigator and national coordinator, reviewing manuscripts for international journals, supervising PhD theses, and managing multi-disciplinary research projects like the COLOS study on COVID-19 outcomes. She is also experienced in translational research linking immunological, metabolic, and renal parameters to improve clinical practice. Assoc. Prof. Dr. Katarzyna Madziarska is an active member of prestigious professional bodies such as the Polish Society of Nephrology (President of the Lower Silesia Branch), Polish Society of Diabetology (Board Member), and the Polish Academy of Sciences Clinical Sciences Committee, where she contributes to advancing healthcare policy and scientific development. Her organizational contributions include serving on the Senate and Faculty Council of Medical Sciences at Wroclaw Medical University, membership in the Bioethics Committee, and participation in the Scientific Council for Clinical Trials, demonstrating her commitment to institutional governance and ethical research conduct.

Profile :  Scopus | ORCID

Featured Publications

  1. Diabetes Mellitus and Old Age – Risk Factors in Renal Replacement Therapy – 2020 – Citations: 48

  2. Evaluation of Immunological Parameters in Lipid Metabolism Disturbances in Primary Glomerulonephritis – 2019 – Citations: 35

  3. Microvascular and Macrovascular Complications in Diabetic Nephropathy: Clinical Predictors and Outcomes – 2021 – Citations: 62

  4. Post-COVID-19 Complications and Kidney Function: A Clinical Perspective – 2022 – Citations: 54

  5. Clinical Trials in Diabetes and Chronic Kidney Disease: Lessons from Multicenter Studies – 2023 – Citations: 39

  6. Role of Molecular Mechanisms in Homeostasis Regulation in Nephrology – 2020 – Citations: 42

 

Jian Liu | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Prof. Jian Liu | Medicine and Health Sciences | Best Researcher Award

Prof. Jian Liu | Medicine and Health Sciences | Director of Anesthesiology Department | Tongji Hospital in Tongji University | China

Prof. Liu Jianhui is the Director of the Department of Anesthesiology at Tongji Hospital, Tongji University, serving as a Professor, Chief Physician, and PhD Supervisor, as well as an Excellent Academic Leader of the Shanghai Municipal Health Commission and a Shanghai Pujiang Talent. She specializes in perioperative neuroimmunology, leading a research team focused on uncovering the mechanisms and developing intervention strategies for perioperative cognitive dysfunction. She has successfully led multiple high-profile research projects, including several funded by the National Natural Science Foundation of China, and has published influential studies in leading journals such as Journal of Neuroinflammation, Anesthesia & Analgesia, Brain, Behavior and Immunity, and British Journal of Anaesthesia. In addition to her research achievements, she serves on the editorial boards of Medical Gas Research and Anesthesia and Perioperative Science, and holds key positions in several national professional committees, reflecting her leadership, academic influence, and dedication to advancing anesthesiology and perioperative medicine.

Professional Profile 

Education  

Prof. Liu Jianhui has pursued an extensive academic path in medicine, specializing in anesthesiology and perioperative medicine, with advanced training that integrates both clinical expertise and research proficiency. She has earned her medical degree followed by postgraduate and doctoral studies, focusing on the intricate mechanisms of perioperative neuroimmunology. Her academic journey has been complemented by specialized training in clinical anesthesia, translational medicine, and neurocognitive function, equipping her with a strong foundation to bridge basic research and clinical application. This comprehensive educational background has enabled her to lead cutting-edge research, mentor doctoral candidates, and contribute significantly to the advancement of anesthesiology at both national and international levels.

Professional Experience

Prof. Liu Jianhui has built a distinguished professional career as Director of the Department of Anesthesiology at Tongji Hospital, Tongji University, where she also serves as Professor, Chief Physician, and PhD Supervisor. She has led numerous research initiatives in perioperative neuroimmunology, with a focus on understanding and addressing perioperative cognitive dysfunction. Her leadership extends beyond the hospital, serving on the editorial boards of Medical Gas Research and Anesthesia and Perioperative Science, and holding prominent roles in national professional societies, including the Standing Committee of the Society of Perioperative Basic and Translational Medicine of the Chinese Society of Anesthesiology, the Society of Innovation and Promotion of Cardiothoracic Anesthesia, and the Society of Anesthesia and Brain Function. Through her clinical expertise, academic leadership, and active participation in professional organizations, she has made significant contributions to advancing anesthesiology and perioperative medicine.

Research Interest

Prof. Liu Jianhui’s research interests center on perioperative neuroimmunology, with a particular focus on the mechanisms and intervention strategies for perioperative cognitive dysfunction. She is dedicated to exploring how surgical and anesthetic factors influence neuroimmune pathways and cognitive outcomes, aiming to identify preventive and therapeutic approaches that can improve patient recovery and quality of life. Her work bridges basic science and clinical practice, integrating molecular, cellular, and systemic perspectives to uncover novel targets for intervention. By combining translational research with clinical application, she strives to advance the understanding of brain function in the perioperative period and contribute to the development of evidence-based strategies that enhance patient care in anesthesiology.

Award and Honor

Prof. Liu Jianhui has been recognized with numerous prestigious awards and honors that reflect her exceptional contributions to anesthesiology and medical research. She has been named an Excellent Academic Leader by the Shanghai Municipal Health Commission and honored as a Shanghai Pujiang Talent, acknowledging her leadership, innovation, and impact in her field. Her achievements in advancing perioperative neuroimmunology and cognitive dysfunction research have earned her national recognition, while her influential publications and service on editorial boards highlight her standing in the international academic community. These distinctions underscore her commitment to excellence, her role as a thought leader, and her significant influence on both clinical practice and scientific advancement.

Publications Top Noted

Preoperative tyrosine is associated with postoperative delayed neurocognitive recovery in elderly: Evidence from two hospitals | Year : 2025

Clinical biomarkers of perioperative neurocognitive disorder: initiation and recommendation | Year : 2025

The Association of Fructose Metabolism With Anesthesia/Surgery-Induced Lactate Production | Year : 2025

Conclusion

Prof. Liu Jianhui’s pioneering research, leadership in anesthesiology, and significant contributions to perioperative neuroimmunology make her a highly deserving candidate for the Best Researcher Award. Her scientific excellence, clinical impact, and commitment to advancing the medical community strongly align with the award’s vision of recognizing transformative contributions to research and healthcare innovation.